Protalix Biotherapeutics Inc
|
Q3 2019
Filed on Nov 12, 2019
|
2,631,400
|
N/A
|
|
Progenics Pharmaceuticals In
|
Q3 2019
Filed on Nov 12, 2019
|
472,580
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
10,000,000
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
40,720
|
$18.62 - $24.51
$758K - $998K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
858,142
|
$1.75 - $2.47
$1.5M - $2.12M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
7,600
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
30,000,000
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
131,573
|
$12.44 - $17.48
$1.64M - $2.3M
|
|
Macquarie Infrastructure Cor
|
Q3 2019
Filed on Nov 12, 2019
|
100,000
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
6,769,297
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
439,853
|
$8.59 - $10.96
$3.78M - $4.82M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
16,180,848
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
74,689
|
$95.8 - $118.9
$7.16M - $8.88M
|
|
Spring Bk Pharmaceuticals In
|
Q3 2019
Filed on Nov 12, 2019
|
31,100
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
47,513
|
$9.41 - $16.56
$447K - $787K
|
|
Portola Pharmaceuticals Inc
|
Q3 2019
Filed on Nov 12, 2019
|
74,800
|
N/A
|
|
Pieris Pharmaceuticals Inc
|
Q3 2019
Filed on Nov 12, 2019
|
364,693
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
227,383
|
$3.08 - $5.76
$700K - $1.31M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
666,589
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
273,947
|
$7.77 - $11.26
$2.13M - $3.08M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
185,899
|
$16.51 - $23.78
$3.07M - $4.42M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
7,985
|
$134.24 - $148.53
$1.07M - $1.19M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
81,528
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
70,088
|
$19.17 - $27.4
$1.34M - $1.92M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
194,991
|
$8.22 - $11.2
$1.6M - $2.18M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
32,000
|
$27.99 - $34.39
$896K - $1.1M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
61,652
|
$32.4 - $49.58
$2M - $3.06M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
22,000
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
123,954
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
1,960
|
$186.69 - $210.18
$366K - $412K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
108,073
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
56,837
|
N/A
|
|
Stemline Therapeutics Inc
|
Q3 2019
Filed on Nov 12, 2019
|
212,936
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
38,438
|
$2.12 - $9.37
$81.5K - $360K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
60,683
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
1,051,126
|
$0.47 - $1.05
$494K - $1.1M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
69,203
|
$6.55 - $8.6
$453K - $595K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
266,877
|
$15.02 - $21.51
$4.01M - $5.74M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
45,700
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
86,596
|
$9.01 - $12.55
$780K - $1.09M
|
|
Actinium Pharmaceuticals Inc
|
Q3 2019
Filed on Nov 12, 2019
|
596,752
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
95,246
|
$7.03 - $9.7
$670K - $924K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
3,500
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
221,297
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
10,000
|
$26.75 - $31.73
$268K - $317K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
83,000
|
$42.77 - $50.71
$3.55M - $4.21M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
188,982
|
$1.5 - $2.99
$283K - $565K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
438,330
|
$1.6 - $2.08
$701K - $912K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
396,526
|
$1.48 - $2.52
$587K - $999K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
92,500
|
N/A
|
|